Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSIGLITAZONE Cause Right ventricular failure? 33 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Right ventricular failure have been filed in association with ROSIGLITAZONE. This represents 0.1% of all adverse event reports for ROSIGLITAZONE.

33
Reports of Right ventricular failure with ROSIGLITAZONE
0.1%
of all ROSIGLITAZONE reports
5
Deaths
30
Hospitalizations

How Dangerous Is Right ventricular failure From ROSIGLITAZONE?

Of the 33 reports, 5 (15.2%) resulted in death, 30 (90.9%) required hospitalization.

Is Right ventricular failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does ROSIGLITAZONE Cause?

Myocardial infarction (17,018) Cardiac failure congestive (15,085) Cerebrovascular accident (7,899) Coronary artery disease (4,982) Acute myocardial infarction (2,437) Cardiac disorder (1,732) Coronary arterial stent insertion (1,698) Coronary artery bypass (1,181) Chest pain (990) Myocardial ischaemia (970)

What Other Drugs Cause Right ventricular failure?

TREPROSTINIL (1,162) MACITENTAN (962) AMBRISENTAN (689) EPOPROSTENOL (585) SELEXIPAG (489) BOSENTAN (365) SILDENAFIL (305) TADALAFIL (250) RIOCIGUAT (232) ILOPROST (133)

Which ROSIGLITAZONE Alternatives Have Lower Right ventricular failure Risk?

ROSIGLITAZONE vs ROSUVASTATIN ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN ROSIGLITAZONE vs ROTIGOTINE ROSIGLITAZONE vs ROXADUSTAT ROSIGLITAZONE vs ROXICODONE

Related Pages

ROSIGLITAZONE Full Profile All Right ventricular failure Reports All Drugs Causing Right ventricular failure ROSIGLITAZONE Demographics